Spanv Medisearch Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 25.00 Cr
as on 12-12-2024
- Paid Up Capital ₹ 1.75 Cr
as on 12-12-2024
- Company Age 6 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 190.00 Cr
as on 12-12-2024
- Satisfied Charges ₹ 272.01 Cr
as on 12-12-2024
- Revenue 57.09%
(FY 2022)
- Profit -114.43%
(FY 2022)
- Ebitda -21.52%
(FY 2022)
- Net Worth -4.78%
(FY 2022)
- Total Assets 1.57%
(FY 2022)
About Spanv Medisearch Lifesciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 25.00 Cr and a paid-up capital of Rs 1.75 Cr.
The company currently has active open charges totaling ₹190.00 Cr. The company has closed loans amounting to ₹272.01 Cr, as per Ministry of Corporate Affairs (MCA) records.
Bhaskara Bollineni, Bollineni Abhinay, Prameela Yalamanchili, and Four other members serve as directors at the Company.
- CIN/LLPIN
U74999MH2018PTC303510
- Company No.
303510
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Jan 2018
- Date of AGM
27 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Spanv Medisearch Lifesciences?
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhaskara Bollineni  | Director | 01-Sep-2022 | Current |
| Bollineni Abhinay | Director | 01-Sep-2022 | Current |
| Prameela Yalamanchili | Director | 18-Mar-2023 | Current |
| Rajkumar Khandelwal | Director | 14-Oct-2022 | Current |
| Mantha Uma | Director | 08-May-2024 | Current |
| Akshay Sancheti | Director | 14-Oct-2022 | Current |
Financial Performance and Corporate Structure Insights of Spanv Medisearch Lifesciences.
Spanv Medisearch Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 57.09% increase. The company also saw a substantial fall in profitability, with a 114.43% decrease in profit. The company's net worth dipped by a decrease of 4.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Spanv Medisearch Lifesciences?
In 2022, Spanv Medisearch Lifesciences had a public holding of 100.00%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kingsway Institute Of Health Sciences Private LimitedActive 4 years 9 monthsRajkumar Khandelwal is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 18 Jan 2023 | ₹190.00 Cr | Open |
Indian Overseas Bank Creation Date: 11 Apr 2022 | ₹101.33 Cr | Satisfied |
Others Creation Date: 30 Sep 2021 | ₹5.36 M | Satisfied |
How Many Employees Work at Spanv Medisearch Lifesciences?
Unlock and access historical data on people associated with Spanv Medisearch Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Spanv Medisearch Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spanv Medisearch Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
